Health, Beauty And Wellness News: Revlon CEO, Rodan + Fields Investment
This article was originally published in The Rose Sheet
Executive Summary
Too Faced fails in appeal of NAD findings; more of same in supplement GMP warnings; vitamin D benefit for in vitro fertilization shown; TropicSport promotes mineral over chemical sunscreens; Rodan + Fields investment by TPG; and Revlon chairman's daughter takes the helm.
You may also be interested in...
Revlon In COVID-19 Tailspin; E-Commerce, At-Home Beauty Provide Lifts
At-home nail and hair care and e-commerce were bright spots in a numbing second quarter for Revlon, which was hit hard by mass retail and salon channel closures at a time of ongoing transformation.
Revlon Doubles China Biz, Grows E-Commerce 66%; But Alas, North America
On the bright side in North America, the Revlon brand has reclaimed its lead in the US mass lip segment, and both Revlon and Almay are off to strong starts in the fourth quarter, company leadership says. The firm continues to build the international and digital sides of its business in search of sustainable growth outside of Elizabeth Arden.
Revlon Highlights Flesh Beauty Launch, China Momentum In Q2 Report
The firm remains in brand- and digital-building mode, but it’s seeing marked progress while looking forward to planned H2 innovations and the impact of its recently introduced Flesh line of “inclusive” color cosmetics. Opportunity beckons in China, where Revlon’s second-quarter sales grew 46%.